This is another type of heart failure where the heart muscle doesn't contract strongly enough during the pumping phase (systole). This makes it harder for the heart to pump blood out to the body, leading to heart failure symptoms.
Every report comes from a Lived member, sent anonymously.
Have you tried Entresto (Sacubitril / Valsartan) for Systolic Heart Failure?
Systolic heart failure, also called heart failure with reduced ejection fraction (HFrEF), means the heart's main pumping chamber, the left ventricle, has become too weak to squeeze out enough blood with each beat. The body's organs and muscles receive less blood than they need, and because blood moves through the heart too slowly, it backs up and fluid leaks into the lungs and other tissues. Those two problems explain the typical symptoms. Shortness of breath often appears first during exertion such as climbing stairs, and later with lighter activity or when lying flat. Tiredness and weakness are common, and fluid can collect in the ankles, legs or belly, adding weight. Some older adults who are not very active notice fatigue or confusion more than breathlessness. Despite the name, heart failure does not mean the heart has stopped or is about to stop. It is a serious, usually long-term condition, and treatment can help many people live longer, feel better and spend less time in the hospital. Systolic heart failure is different from heart failure with preserved ejection fraction, in which the heart pumps normally but is too stiff to fill properly. The two are treated differently, so knowing which type someone has matters.
Systolic heart failure develops when something damages or weakens the heart muscle. A common cause is coronary artery disease, in which narrowed arteries starve the heart muscle of oxygen; a heart attack can leave part of the muscle permanently scarred. Other causes include long-standing high blood pressure, faulty heart valves, an irregular heartbeat such as atrial fibrillation, heart conditions present from birth or inherited diseases of the heart muscle (cardiomyopathies), heavy alcohol use, cocaine use, certain infections, and some cancer treatments, including certain chemotherapy drugs and radiation. Risk rises with age, especially after 65, and with diabetes, obesity, smoking, chronic kidney disease and sleep apnea. Heart failure is more common and tends to start earlier in Black Americans, and men are more likely than women to have the reduced ejection fraction type. These are risk factors, not certainties. Finding the specific cause matters, because treating a blocked artery, a valve problem or a rhythm disturbance can sometimes allow the heart to recover some of its strength.
Diagnosis starts with symptoms, medical and family history, and a physical exam that looks for signs of fluid buildup. A blood test for brain natriuretic peptide (BNP), or the related NT-proBNP, is useful because the heart releases these substances when it is under strain. A low level makes heart failure less likely, while higher levels support the diagnosis and reflect how severe it is. Other blood tests check how well the kidneys and liver are working. The key test is an echocardiogram, an ultrasound of the heart, which measures the ejection fraction: the percentage of blood in the left ventricle that is pumped out with each beat. An ejection fraction of 40% or less, together with symptoms of heart failure, defines systolic heart failure. A value of 50% or more with heart failure symptoms points to the preserved type, and 41% to 49% is an in-between category called mildly reduced (or borderline). The number also guides treatment; some devices are considered only when it stays at 35% or lower despite medicines. Further tests look for the cause. An electrocardiogram (ECG) records the heart's rhythm and electrical pattern, and a coronary angiogram or CT scan can show narrowed arteries. Cardiac MRI can help when the echocardiogram is unclear or an unusual heart muscle disease is suspected, and genetic testing may be offered when cardiomyopathy runs in the family.
There is no cure for most systolic heart failure, but treatment can help people live longer, stay out of the hospital and have fewer symptoms, and in some people it lets the heart muscle partly recover. Guidelines in the United States and elsewhere agree on four types of medicine that form the foundation of treatment, and starting them early after diagnosis reduces the risk of death. The first type blocks a hormone system that tightens blood vessels and makes the body hold on to salt and water. US guidelines prefer sacubitril/valsartan (Entresto) for this role, with an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) as alternatives. The second is a beta blocker shown to work in heart failure, such as carvedilol, bisoprolol or metoprolol succinate, which slows the heart rate and helps keep heart failure from worsening over time. The third is a mineralocorticoid receptor antagonist such as spironolactone, which blocks aldosterone, a hormone that drives salt and fluid retention. The fourth is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin (Farxiga) or empagliflozin (Jardiance). These began as diabetes medicines and are now approved to reduce deaths and hospital stays from heart failure whether or not a person has diabetes. These medicines are usually started at low doses and increased over weeks to months toward the doses shown to work. Regular blood tests check kidney function and potassium, because several of them can raise potassium, and low blood pressure is a common reason doses need adjusting. Medicines in the first group can harm a developing baby, so anyone who could become pregnant should discuss contraception and pregnancy plans with their care team. Diuretics (water pills) are added to clear extra fluid and relieve breathlessness and swelling, at the lowest dose that keeps fluid off. Other medicines may be added in particular situations, for example the combination of hydralazine and isosorbide dinitrate, which improves survival in Black patients. When the ejection fraction stays at 35% or lower after about three months of medicines, devices may be considered. An implantable cardioverter-defibrillator (ICD) watches the heart rhythm and delivers a shock to stop a dangerous rhythm that could cause sudden cardiac arrest. Cardiac resynchronization therapy (CRT), a special pacemaker, helps both sides of the heart contract together when an ECG shows a delay in the heart's electrical signal; it can improve symptoms and survival. Some devices do both. Treating the underlying cause is part of the plan, such as opening or bypassing blocked arteries or repairing a leaking valve. Daily habits support the medicines: limiting salt (and sometimes fluids), staying physically active, often through a supervised cardiac rehabilitation program, not smoking, and limiting or avoiding alcohol. For advanced heart failure that no longer responds to these measures, options include a mechanical heart pump (ventricular assist device), heart transplant, and palliative care focused on comfort and quality of life.
Systolic heart failure is usually a lifelong condition, and its course varies widely. Some people feel much better once treatment is under way, and studies suggest that roughly one in five sees their ejection fraction improve substantially. Even then, medicines are usually continued, because in studies of people whose hearts improved, a substantial share weakened again when treatment was stopped. For others, heart failure gradually worsens over years despite treatment, with stable periods interrupted by flare-ups of fluid buildup that may need a hospital stay. Daily life involves taking several medicines regularly, eating less salt and watching for early signs that fluid is building up. Care teams usually ask people to check their weight regularly and tell them what change to report. Visits and blood tests are frequent in the first months while doses are adjusted, then less frequent once treatment is stable, and repeat echocardiograms show whether the heart is responding. Some medicines can make heart failure worse, so it helps to tell every prescriber and pharmacist about the diagnosis and every medicine you take. Living with heart failure can bring fear, anxiety and depression, and treating depression can improve quality of life; support groups and counseling help many people cope. Because heart failure can change over time, it is worth talking with family and the care team about goals and preferences for future care, including advance directives, while you are well enough to make those decisions.
See a clinician if you develop breathlessness with ordinary activity, swelling in the ankles or legs, or tiredness you can't explain, particularly if you have heart disease, high blood pressure or diabetes. If you already have heart failure and a medicine seems to cause side effects, contact the prescriber to adjust the plan rather than stopping it on your own. Contact your care team without waiting for your next appointment if your weight rises by more than the amount they told you to watch for, swelling in your legs or belly increases, you become short of breath at rest, or you feel constantly exhausted. These often mean fluid is building up, and treating it early can sometimes prevent a hospital stay. Call 911 for new chest pain, severe trouble breathing, or heart failure symptoms that suddenly become much worse.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Systolic Heart Failure is like, what's helped you, or ask the community a question.